84 completed, 31 unknown, 23 recruiting, 12 not yet recruiting. 178 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 178 | Completed 84, Unknown 31, Recruiting 23, Not yet recruiting 12, Terminated 12, Active not recruiting 9, Withdrawn 5, Enrolling by invitation 1, Suspended 1 |
Follow Injections: new trials by email Literature Review of Injections trials Research Report on Injections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sequential Treatment With Romosozumab Followed by Denosumab vs. Zoledronic Acid for Gains in HIP BMD Romosozumab, Zoledronic Acid 5 MG in 5 ML Injection, Calcium 500 mg and Vitamin D3 800 IU - Osteoporosis in Post-menopausal Women | Phase 4 | Not yet recruiting | Sahlgrenska University Hospital | 216 | 2027-01-11 | 2026-08-19 |
| Broadening Antiemetics Research by Comparing the Effectiveness of Fosaprepitant and Metoclopramide Fosaprepitant for Injection, Metoclopramide Injection - Nausea and Vomiting, Nausea | Phase 4 | Not yet recruiting | Montefiore Medical Center | 212 | 2026-12-01 | 2026-06-29 |
| CYTALUX Dose Extension Study CYTALUX (pafolacianine) injection - Cancer in the Lung, Ovarian Cancer | Phase 4 | Not yet recruiting | On Target Laboratories, LLC | 106 | 2026-11-15 | 2026-11-09 |
| Airway Dysfunction, Occlusions and Remodeling: COPD Patients and Mepolizumab Mepolizumab 100 MG Injection - COPD (Chronic Obstructive Pulmonary Disease) | Phase 4 | Not yet recruiting | Western University, Canada | 36 | 2026-10-01 | 2026-08-06 |
| Efficacy of Clobetasol Vs Intralesional Triamcinolone in Lichen Planus Treatment Clobetasol propionate 0.05% cream, Triamcinolone acetonide 10 mg/mL injection - Hypertrophic Lichen Planus | Phase 4 | Not yet recruiting | Noor Aziz | 50 | 2026-10-01 | 2026-06-24 |
| A Clinical Trial of Taibowei® Adalimumab Injection in the Treatment of Chinese Pediatric Patients With Moderately to Severely Active Crohn's Disease Adalimumab Solution for Injection - Children Aged 6 Years and Above With Moderate - to - Severe Active Crohn's Disease | Phase 4 | Recruiting | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 30 | 2026-08-13 | 2026-09-10 |
| Success Rates and Safety of Steroid Injections in Managing Spinal and Sacro-Iliac Pain (CORTisone Injection Spine Study) triamcinolone acetonide (Kenalog), Celestone Soluspan 6Mg/Ml Suspension for Injection, Depo-Medrol 40Mg/Ml Suspension for Injection - Back Pain Lower Back, Neck Pain | Phase 4 | Recruiting | Igor Wilderman. MD | 500 | 2026-07-30 | 2026-08-13 |
| Efficacy of Faricimab in Patients With Subretinal Hyper-reflective Material Vabysmo 6 MG in 0.05 ML Injection - Macular Degeneration, Age Related | Phase 4 | Recruiting | Biobizkaia Health Research Institute | 100 | 2026-05-25 | 2026-05-28 |
| Sodium Bicarbonate for Critically Ill Patients With Metabolic Acidosis and Acute Kidney Injury Sodium Bicarbonate 8.4% Solution for Injection, Balanced crystalloid solution - Acute Kidney Injury, Metabolic Acidosis | Phase 4 | Recruiting | Universität Münster | 660 | 2026-05-07 | 2026-09-04 |
| A Clinical Trail of Adalimumab in Treating Chinese Children With Severe Plaque Psoriasis Adalimumab Solution for Injection - Severe Plaque Psoriasis in Chinese Children | Phase 4 | Not yet recruiting | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 30 | 2026-05-01 | 2026-04-14 |
| Preventing Structural Damage in Early Psoriatic Arthritis Amgevita 40Mg Solution for Injection, Methotrexate (Metoject® prefilled pen) - Psoriatic Arthritis (PsA) | Phase 4 | Recruiting | Chinese University of Hong Kong | 108 | 2026-03-16 | 2026-03-23 |
| Low Level Laser Therapy With Injectable Platelet Rich Fibrin in Management of Oral Lichen Planus Injectable Platelet Rich Fibrin, Low Level Laser Therapy, Triamcinolone acetonide (injection) - Oral Lichen Planus | Phase 4 | Active not recruiting | Ain Shams University | 39 | 2026-03-15 | 2026-09-29 |
| An Exploratory Study on Efficacy and Safety of Fosaprepitant and Palonosetron Hydrochloride for Injection in Preventing CINV From Multi-Agent HEC Fosrolapitant and Palonosetron Hydrochloride for Injection, Dexamethasone, Olanzapine - Chemotherapy-induced Nausea and Vomiting | Phase 4 | Recruiting | Shanghai 6th People's Hospital | 200 | 2026-03-10 | 2026-04-30 |
| A Randomized, Controlled Clinical Trial Comparing Remimazolam Besylate Combined With Alfentanil Versus Propofol Combined With Alfentanil for Anesthesia in Thoracic Surgery Remimazolam Besylate for Injection, Propofol, Alfentanil Hydrochloride Injection - Thoracic Surgery, Anesthesia | Phase 4 | Not yet recruiting | The First Affiliated Hospital of Xinxiang Medical College | 50 | 2026-03-01 | 2026-01-16 |
| Post-Prandial Carbohydrate Metabolism in Individuals With and Without Post-Bariatric Surgery Hypoglycemia (PBH) Glucagon for Injection (Fresenius Kabi USA), [6,6-2H2] glucose, [13C9, 15N1]-glucagon - Hypoglycemia, Hypoglycemia, Reactive | Phase 4 | Recruiting | Joslin Diabetes Center | 40 | 2026-01-27 | 2026-09-14 |
| Colistin and Meropenem Versus Amikacin and Meropenem for MDR Gram Negative Bacteria Regarding Efficacy and Safety. Colistimethate sodium for injection, meropenem, Amikacin Injection and meropenem - MDR Bacteria | Phase 4 | Active not recruiting | Beni-Suef University | 100 | 2025-12-30 | 2026-07-14 |
| Early Administration of PCSK9 Inhibitors After Thrombectomy for Atherosclerotic Acute Ischemic Stroke: A Randomized Controlled Trial Evolocumab(420 mg injections) - Acute Stroke | Phase 4 | Completed | The Affiliated Hospital of Xuzhou Medical University | 60 | 2025-12-20 | 2026-07-13 |
| Clinical Study on the Effect of Tegileridine on Postoperative Pain in Patients Undergoing Abdominal Surgery. Tegileridine (tegileridine fumarate injection, IV), 0.9% Normal Saline (0.9% Sodium Chloride) injection - Laparoscopic Surgery for Cholecystitis | Phase 4 | Completed | Xin Chen | 150 | 2025-11-30 | 2026-04-13 |
| Preoperative BOTOX® Injection for Large Ventral Hernia Repair OnabotulinumtoxinA Injection, Saline (placebo) Injection, OnabotulinumtoxinA - Hernia Abdominal Wall, Botox Injection | Phase 4 | Recruiting | The Cleveland Clinic | 188 | 2025-11-03 | 2026-10-26 |
| Beyond EOsinophils: proteoMICS to Identify Potential Biomarker of Organ Damage and Response to MEPOLIZUMAB in EGPA Mepolizumab 100 MG Injection [Nucala], Mepolizumab 300 mg - EGPA - Eosinophilic Granulomatosis With Polyangiitis, Severe Asthma | Phase 4 | Enrolling by invitation | Azienda Ospedaliero Universitaria di Cagliari | 90 | 2025-10-17 | 2026-01-15 |
Showing 20 of 178. Sign in to see all of them.
Pain, Postoperative (10) · Obesity (9) · Hypogonadism (4) · Insulin Resistance (4) · Ischemic Stroke (4) · Pain (4) · Agnosia (3) · COVID-19 (3) · Postoperative Complications (3) · Sepsis (3) · Acute Kidney Injury (2) · Acute Pain (2) · Alopecia (2) · Anemia, Iron-Deficiency (2) · Brain Edema (2)
University Medical Centre Ljubljana (5) · Gulhane School of Medicine (3) · Peking University First Hospital (3) · University of California, San Diego (3) · Ain Shams University (2) · Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. (2) · Cedars-Sinai Medical Center (2) · Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (2) · Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (2) · Hospital for Special Surgery, New York (2) · Joslin Diabetes Center (2) · King Chulalongkorn Memorial Hospital (2) · Northwestern University (2) · The Cleveland Clinic (2) · The Third Affiliated hospital of Zhejiang Chinese Medical University (2)
United States (45) · China (28) · Egypt (8) · Spain (8) · Canada (7) · Turkey (Türkiye) (6) · United Kingdom (6) · Australia (4) · Germany (4) · Poland (4) · Slovenia (4) · South Korea (4) · Sweden (4) · Belgium (3) · Israel (3)
Andrej Janez, MD, PhD (2) · Dong-Xin Wang, MD, PhD (2) · Yi Mo, Master (2) · Abduraheem Mohamed, MBBS,BSc,MRCS (1) · Ad Masclee, MD, PhD (1) · Ahmed M Shaat, MD (1) · Ahmet B. Erdem (1) · Ailin Luo, Doctor (1) · Alexander Zarbock, MD (1) · Ali A Lanewala, MD, PhD (1) · Ananda Basu, MD (1) · Andrej Alfirevic, MD (1) · Andrej Janez, MD PhD (1) · Andres F Estupinan Bohorquez, MD (1) · Anette-G. Ziegler (1)
PMID 22067185, PMID 10394018, PMID 10394019, PMID 10740539, PMID 11020772, PMID 1135616, PMID 11561801, PMID 12145716, PMID 16846542, PMID 18183534, PMID 20027030, PMID 22179931, PMID 22623080, PMID 23152677, PMID 23300227, PMID 23598289, PMID 24002794, PMID 24157979, PMID 24694530, PMID 24799137, PMID 24817851, PMID 25129820, PMID 25170277, PMID 25293517, PMID 25330463, PMID 25770310, PMID 25840339, PMID 25870613, PMID 26077459, PMID 26543383, PMID 27156796, PMID 27191923, PMID 27552990, PMID 27788880, PMID 27855722, PMID 27888762, PMID 28182690, PMID 28420629, PMID 28510679, PMID 2855531, PMID 28626052, PMID 29183393, PMID 29487073, PMID 29729645, PMID 29984566, PMID 30219400, PMID 30426190, PMID 30762779, PMID 30881102, PMID 31162798
2025 (2), R01DK137518 (2), 2009 (1), 2023 (1)